Clinical Trial Update: Effects of Growth Hormone on Exercise Capacity [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating growth hormone on exercise capacity in chronic heart failure has completed. Sponsor: Federico II University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Federico II University | Conditions: Chronic Heart Failure | Phase 3 | Status: COMPLETED